Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLiontrust Asset Management Regulatory News (LIO)

Share Price Information for Liontrust Asset Management (LIO)

Share Price is delayed by 15 minutes
Get Live Data
303.50    -5.50 (-1.78%)
Bid:
303.00
Ask:
304.00
Spread: 1.00 (0.33%)
Market Cap: £180.40m
LIO Live PriceLast checked at - London Stock Exchange

Intraday Liontrust Asset Management Share Chart

Transaction in Own Shares

15 Apr 2026 07:00

RNS Number : 4718A
Liontrust Asset Management PLC
15 April 2026
 

LEI: 549300XVXU6S7PLCL855

15 April 2026

Liontrust Asset Management Plc

("Liontrust" or the "Company")

Transaction in Own Shares

Liontrust, the independent fund management group, announces that in accordance with the Company's Share Buyback programme, as outlined in its announcement on 27 November 2025, that it has purchased 20,781 of its ordinary shares ("Shares") at a price of 253.41 pence per Share. The purchased Shares will be cancelled.

Aggregated information

Date of purchase

14 April 2026

Number of Shares purchased

20,781

Highest price paid per Share

255.00p

Lowest price paid per Share

251.50p

Volume weighted average price paid

253.41p

 

Transaction details

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation) (which forms part of domestic UK law pursuant to the European Union (Withdrawal) Act 2018), a detailed breakdown of individual trades is available below:

Shares

Price

Time

Venue

245

253

08:07:01

XLON

234

252.5

08:11:00

XLON

179

252

08:16:00

XLON

150

252

08:16:00

XLON

236

252

08:22:00

XLON

14

251.5

08:36:41

BATE

53

252.5

08:37:00

XLON

298

252.5

08:37:07

XLON

150

252.5

08:38:20

CHIX

468

253

08:39:43

XLON

683

252

08:53:35

XLON

184

252.5

08:53:35

CHIX

854

252

09:41:31

XLON

208

252

09:41:31

CHIX

1081

252

09:41:31

BATE

250

252.5

09:41:31

XLON

122

252.5

09:41:31

XLON

30

252.5

09:41:31

XLON

109

252.5

09:41:31

XLON

1076

252.5

09:46:16

BATE

455

252.5

09:51:19

XLON

39

252.5

09:51:19

XLON

355

252

09:58:06

BATE

505

252

09:58:06

XLON

380

252.5

10:15:39

BATE

1

252.5

10:29:44

BATE

510

252.5

10:29:44

XLON

441

252.5

10:29:50

BATE

13

253.5

11:26:07

TRQX

217

253.5

11:26:07

CHIX

54

253.5

11:26:07

TRQX

557

254

11:41:30

XLON

707

254

11:41:30

BATE

303

254

11:41:30

BATE

333

253.5

11:58:00

XLON

127

253.5

11:58:00

CHIX

131

253.5

11:58:00

TRQX

95

253

12:04:36

TRQX

376

253

12:04:36

XLON

30

253

12:04:36

TRQX

266

252.5

12:05:47

XLON

450

252.5

12:06:11

XLON

395

253.5

12:36:01

XLON

148

253.5

12:47:49

XLON

30

253.5

12:47:49

XLON

1134

255

12:59:01

XLON

699

254

13:00:37

BATE

438

254

13:09:11

XLON

167

254

13:09:11

CHIX

592

255

13:21:32

XLON

595

255

13:21:32

BATE

332

254.5

13:24:32

XLON

67

255

13:31:45

TRQX

1190

255

15:25:43

BATE

1690

255

15:25:43

XLON

335

255

15:35:49

XLON

 

Following the purchase, the Company's total issued share capital consists of 61,593,284 Shares. The Company does not hold any Shares in treasury therefore, the total number of Shares carrying voting rights in the Company is 61,593,284.

The above figure of 61,593,284 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Liontrust Asset Management Plc (Tel: 020 7412 1700, Website: Liontrust.com)

Stephen Corbett: Head of Investor Relations

Simon Hildrey: Chief Marketing Officer

 

Panmure Liberum (Tel: 020 7886 2500)

Corporate Broking: David Watkins

Corporate Advisory: Atholl Tweedie

 

Singer Capital Markets (Tel: 020 7496 3000)

Corporate Broking: Charles Leigh-Pemberton

Corporate Advisory: James Moat

 

Berenberg (Tel: 020 3207 7800)

Investment Banking: James Felix, John Welch, Dan Gee-Summons

 

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSQZLFFQZLZBBE
Date   Source Headline
1st Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20267:00 amRNSTotal Voting Rights
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSAppointment of Joint Corporate Broker
30th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSProposed Acquisition of River Global Holdings Ltd
16th Mar 20267:00 amRNSProposed Acquisition of River Global Holdings Ltd
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20269:36 amRNSTotal Voting Rights
26th Feb 202611:35 amRNSForm 8.3 - ESSENSYS
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20261:28 pmRNSForm 8.3 - ESSENSYS
25th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20262:29 pmRNSForm 8.3 - ESSENSYS PLC
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20261:46 pmRNSForm 8.3 - Oxford Biomedica Plc
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20262:40 pmRNSForm 8.3 - Kitwave group plc
18th Feb 20262:37 pmRNSForm 8.3 - Oxford Biomedica Plc
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20263:20 pmRNSForm 8.3 - ESSENSYS PLC
17th Feb 20263:19 pmRNSForm 8.3 - KITWAVE GROUP PLC
16th Feb 20262:51 pmRNSForm 8.3 - Oxford Biomedica Plc
13th Feb 202610:13 amRNSHolding(s) in Company
13th Feb 202610:11 amRNSHolding(s) in Company
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 202611:15 amRNSForm 8.3 - KITWAVE GROUP PLC
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 202612:07 pmRNSForm 8.3 - Kitwave Group Plc
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20263:25 pmRNSForm 8.3 - KITWAVE GROUP PLC
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20262:27 pmRNSForm 8.3 - Kitwave group plc
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.